arrow
J

James A. Roper

galecto biotech aps
H指数:19
被引数:1,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 Inhibitor

一种口服可用的卤代噻唑类糖模拟物作为靶向癌细胞的半乳糖凝集素-1和半乳糖凝集素-3双重抑制剂

2026-04-290
PRE
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer

发现选择性和口服Galectin-1抑制剂GB1908作为肺癌的潜在治疗方法

2024-05-287
PRE
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

用于治疗纤维化疾病的首个高效且可口服的Galectin-3抑制剂的发现和优化

2022-09-2647
OAAI
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease
2021-12-018
PRE
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis
2020-09-1679
OAAI
Profile of a Highly Selective Quaternized Pyrrolidine Betaine αvβ6 Integrin Inhibitor-(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective Methylation
2019-08-055
OAAI